Invention Grant
- Patent Title: Therapeutic inhibitory compounds
-
Application No.: US16009093Application Date: 2018-06-14
-
Publication No.: US10308637B2Publication Date: 2019-06-04
- Inventor: Andrew McDonald , Shawn Qian
- Applicant: LifeSci Pharmaceuticals, Inc.
- Applicant Address: BB Bridgetown, St. Michael
- Assignee: LIFESCI PHARMACEUTICALS, INC.
- Current Assignee: LIFESCI PHARMACEUTICALS, INC.
- Current Assignee Address: BB Bridgetown, St. Michael
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D413/14 ; C07D471/04 ; C07D487/04
Abstract:
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma kallikrein. Furthermore, the subject compounds and compositions are useful for the treatment of diseases wherein the inhibition of plasma kallikrein inhibition has been implicated, such as angioedema and the like.
Public/Granted literature
- US20190002437A1 THERAPEUTIC INHIBITORY COMPOUNDS Public/Granted day:2019-01-03
Information query
